Mucin glycan GlcNAc-α-1,4-Gal structure (αGlcNAc) (αGlcNAc)

Mucin glycan GlcNAc-α-1,4-Gal structures are specialized O-glycans characterized by a terminal α1,4-linked N-acetylglucosamine residue [NIH]. These structures are primarily found on the MUC6 scaffold protein within the gastric mucosa, Brunner's glands of the duodenum, and accessory glands of the biliary tract [NIH, ResearchGate]. They serve a critical biological role as a natural antibiotic, specifically inhibiting the growth of Helicobacter pylori by interfering with the synthesis of its essential cell wall component, α-glucosyl cholesterol [NIH]. Additionally, these glycans act as ligands for the Trefoil Factor Family (TFF) proteins, which are essential for maintaining the viscoelasticity and protective barrier function of the oral and gastrointestinal mucus [Wikipedia, ResearchGate]. In disease states, the loss of these glycans is a hallmark of gastric and pancreatic cancer progression and is associated with poor prognosis [NIH, ResearchGate]. Therapeutic strategies focus on using these structures as biomarkers for early cancer detection or developing glycomimetics to treat H. pylori infections and prevent associated gastric pathologies [NIH]. The enzyme α1,4-N-acetylglucosaminyltransferase (α4GnT) is responsible for their biosynthesis and is itself a target for research into mucosal protection [NIH].

Other names

α1,4-linked N-acetylglucosamineα1,4-GlcNAc-capped O-glycanClass III mucin glycanα1,4-GlcNAcGlcNAc-α-1,4-Gal

Inhibition of Helicobacter pylori cholesterol α-glucosyltransferase (HP0421); Interaction with Trefoil Factor Family (TFF) proteins to modulate mucus properties